Sidvim Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 18-07-2024
- Paid Up Capital ₹ 2.60 M
as on 18-07-2024
- Company Age 15 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 0.96%
(FY 2023)
- Profit 11.81%
(FY 2023)
- Ebitda 9.92%
(FY 2023)
- Net Worth 10.13%
(FY 2023)
- Total Assets 7.97%
(FY 2023)
About Sidvim Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.60 M, as per Ministry of Corporate Affairs (MCA) records.
Jagdish Dore, Govindarajan Venkatachary, Satish Bijoor, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74990MH2009PTC196378
- Company No.
196378
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2009
- Date of AGM
19 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sidvim Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdish Dore  | Managing Director | 09-Oct-2009 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shireesh Ambhaikar | Whole-Time Director | 15-Oct-2023 | Current |
| Satish Bijoor | Director | 09-Oct-2009 | Current |
| Govindarajan Venkatachary | Whole-Time Director | 02-Jun-2017 | Current |
| Meghana Inamdar | Whole-Time Director | 19-Nov-2021 | Current |
Financial Performance of Sidvim Lifesciences.
Sidvim Lifesciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.96% increase. The company also saw a substantial improvement in profitability, with a 11.81% increase in profit. The company's net worth Soared by an impressive increase of 10.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sidvim Lifesciences?
In 2023, Sidvim Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sidvim Ventures Private LimitedActive 12 years 7 monthsJagdish Dore and Govindarajan Venkatachary are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sidvim Lifesciences?
Unlock and access historical data on people associated with Sidvim Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sidvim Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sidvim Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
